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The pyrethroid knockdown resistance gene (kdr) has
become widespread in Anopheles gambiae in West Africa.
A trial to test the continuing efficacy of insecticide-treated
nets (ITN) and indoor residual spraying (IRS) was under-
taken in experimental huts at 2 sites in Benin, the first
where kdr is present at high frequency (Ladji), the second-
where An. gambiae is susceptible (Malanville). Holes were
made in the nets to mimic worn nets. At Malanville, 96% of
susceptible An. gambiae were inhibited from blood-feeding,
whereas at Ladji feeding was uninhibited by ITNs. The mor-
tality rate of An. gambiae in ITN huts was 98% in Malanville
but only 30% at Ladji. The efficacy of IRS was equally com-
promised. Mosquitoes at Ladji had higher oxidase and
esterase activity than in a laboratory-susceptible strain, but
this fact did not seem to contribute to resistance. Pyrethroid
resistance in An. gambiae appears to threaten the future of
ITN and IRS in Benin.
D
uring the last decade, pyrethroid-treated mosquito
nets have become the main method of malaria preven-
tion in many malaria-endemic African countries (1,2). In a
few notable exceptions, usually those with a more devel-
oped health infrastructure, such as South Africa, a long-
standing practice of applying indoor residual spraying
(IRS) has been successful (3). The 2 approaches to malar-
ia prevention, insecticide-treated nets (ITNs) and spraying
(IRS), are not mutually exclusive, and in malaria-endemic
areas where ITN coverage is still limited, the feasibility of
introducing IRS to reduce transmission is being consid-
ered, for example, by the President’s Malaria Initiative
Fund (4). Trials of IRS and ITNs have shown that in areas
with pyrethroid-susceptible Anopheles gambiae the effec-
tiveness of the 2 methods in controlling malaria does not
differ (5). This comparability may not hold true for areas
with pyrethroid-resistant populations. In southern Africa,
for example, IRS with pyrethroid failed to control
pyrethroid-resistant An. funestus and necessitated a switch
to an alternative class of insecticide to which there was no
resistance (6). During the last decade, pyrethroid resist-
ance caused by the kdr mechanism has become widespread
in An. gambiae in West Africa and is common in some
areas (7). Whether kdr undermines the effectiveness of
ITN in areas of high prevalence is unclear. An early exper-
imental hut trial of ITNs in Côte d’Ivoire demonstrated a
survival advantage of homozygotes for kdr resistance (8),
whereas subsequent hut trials in adjacent resistant and sus-
ceptible populations showed no apparent difference in the
effectiveness of ITNs between the 2 localities (9). Village
randomized trials in Côte d’Ivoire showed that ITNs con-
tinued to prevent malaria despite a vector population that
was kdr resistant (10). Whether kdr would undermine the
effectiveness of IRS in the same way as resistance due to
oxidases did against An. funestus in southern Africa (6) is
unknown. To assess the practicability of applying IRS with
pyrethroid in West Africa, we need to examine the effec-
tiveness of this approach against a kdr-resistant population
of An. gambiae. To get a clearer understanding of the influ-
ence of kdr resistance on the effectiveness of ITN, further
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lations need to be conducted. We describe 2 experimental
hut trials in Benin. One compares the impact of IRS and
ITN against a pyrethroid- resistant population in the south-
ern part of the country; the other compares IRS and ITNs
against a pyrethroid-susceptible population several hun-
dred kilometers to the north.
Material and Methods
Study Sites
Ladji is a large village on the outskirts of Cotonou, the
capital of Benin. The village floods during the rainy sea-
son. An. gambiae comprises the Mopti (M) cytotype and
shows resistance to pyrethroids and DDT; kdr is present at
high frequency (11). The nuisance mosquito Culex quin-
quefasciatus is also present and shows resistance to
pyrethroids. Five experimental huts belonging to the
Centre de Recherche Entomologique de Cotonou (CREC)
are situated in the village.
Malanville is in northern Benin, 800 km from
Cotonou, in an irrigated rice-growing valley. The local An.
gambiae comprises the M cytotype, but the kdr gene is
almost absent and mosquitoes are susceptible to lambda-
cyalothrin and deltamethrin. Six experimental huts are
present at Malanville.
Experimental Huts
The treated nets, residual spray treatments, and their
respective untreated controls were evaluated in 4 experi-
mental huts at each field site. Experimental huts are spe-
cially designed to test vector control products against
freely entering mosquitoes under natural but controlled
conditions. Huts were typical of the region. Each was
made from concrete bricks, with a corrugated iron roof and
a ceiling of thick polyethylene sheeting lined with hessian
sackcloth on the interior surface, and each was built on a
concrete base surrounded by a water-filled moat to exclude
ants (12). Mosquito access was through 4 window slits,
constructed from pieces of plywood fixed at an angle to
create a funnel with a 1-cm gap, present on 3 sides of the
huts. Mosquitoes had to fly upward to enter through the
gaps and downwards to exit; this precluded or limited exo-
dus through the aperture and enabled us to account for
most entering mosquitoes. A veranda trap projected from
the back wall of each hut. Movement of mosquitoes
between a room and the veranda was unimpeded.
Mosquito Net Treatments
The nets were made of white, 100-denier polyester
(SiamDutch Mosquito Netting Co., Bangkok, Thailand).
Nets measured 2.0-m long, 1.6-m wide, and 1.8-m tall and
had a surface area of 16.9 m2. To simulate badly torn nets,
80 holes, each measuring 2 × 2 cm, were cut in the sides
and ends of each net.
Insecticides used were formulations of lambdacy-
halothrin (Icon, Syngenta, Switzerland): lambdacy-
halothrin 2.5% CS, a microencapsulated suspension
designed for ITNs, and lambdacyhalothrin 10% WP, a wet-
table powder designed for IRS.
The lambdacyhalothin application rates of 18 mg/m2
for ITNs and 30 mg/m2 for IRS were within the ranges rec-
ommended by the manufacturer. Indoor residual treat-
ments were applied with a hand-operated compression
sprayer equipped with a flat fan nozzle. The cement walls
and sackcloth ceilings were sprayed uniformly after mask-
ing the veranda and window slits with protective cover-
ings. The control hut was sprayed with water only. The
treated huts were left for 1 week before evaluations were
started.
Sleepers and Mosquito Collections
Preliminary experiments showed the huts to be even-
ly attractive to mosquitoes. The treatments were randomly
allocated to the 4 experimental huts at each site. The main
trials were conducted from April to June 2005 at the Ladji
site and from September to November 2005 at the
Malanville site. Eight adult men employed by CREC slept
overnight in the huts and collected mosquitoes from the
huts in the mornings. Informed consent to participate in the
study was given beforehand, and chemoprophylaxis was
provided during the trial. Ethical approval was granted by
the London School of Hygiene and Tropical Medicine
(LSHTM) and Benin national ethics committees.
The trial ran for 50 nights for 8 weeks at each site. The
sleepers were rotated between huts to correct for possible
variation in individual attractiveness. Each morning, mos-
quitoes were collected from the floors, walls, and ceilings
of rooms, verandas, and nets with aspirators and torches.
Mosquitoes were identified and scored as blood-fed or
unfed and dead or live. Live mosquitoes were held in net-
ted plastic cups and supplied with 10% honey solution for
24 h before delayed mortality was recorded. Male mosqui-
toes were not scored.
The entomologic impact of each treatment on mosqui-
toes was expressed relative to the control in terms of the
following: deterrence, the proportional reduction in the
number of mosquitoes entering a treated hut relative to that
entering the control hut; induced exophily, the proportion
of mosquitoes collected from the veranda trap of the treat-
ment hut relative to the proportion in the veranda of the
control hut; blood-feeding inhibition, the reduction in
blood-feeding rate relative to the control hut; and mortali-
ty, the proportions of mosquitoes found dead in the hut at
the time of collection and after a 24-h holding period.
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quitoes from entering the hut, the values given by propor-
tion blood-feeding or proportion killed in the treatment hut
may underestimate the full personal protective effect and
overestimate the full insecticidal efficacy of the treatment.
The personal protective effect of a treatment is better
described by the reduction in the number of blood-fed
mosquitoes in the treatment hut relative to the number
blood-fed in the control hut:
% Personal protection = 100 (Bu – Bt)/Bu
where Bu  is the total number of blood-fed mosquitoes in
the untreated control huts and Bt is the total number blood-
fed mosquitoes in the huts with insecticide treatment.
The overall insecticidal effect of a treatment needs to
take into account that a considerable number of mosqui-
toes might be deterred from entering the hut and hence not
be killed by the treatment. Amass killing effect is desirable
to reduce transmission. The overall insecticidal effect of a
treatment relative to the number of mosquitoes that would
ordinarily enter an untreated hut can be estimated by using
the following formula and expressed as a percentage:
Overall insecticidal effect (%) = 100 (Kt – Ku)/(Tu – Ku)
where Kt is the number killed in the treated hut, Ku is the
number dying in the untreated control hut, and Tu is the
total number collected from the control hut.
Residual Activity of Insecticide Treatments
To evaluate residual activity, World Health
Organization (WHO) cone bioassays were undertaken
monthly in the Ladji huts and bimonthly in the Malanville
huts with a laboratory-susceptible strain of An. gambiae
(Kisumu).  An. gambiae females, 3–5 days old, were
exposed within the cones to nets for 3 min or to sprayed
walls and ceilings for 30 min. Approximately 50 mosqui-
toes in 5 replicates of 10 mosquitoes were tested on each
substrate. Honey solution was provided during the 24-h
holding period, and the temperature was kept at 25°C.
Biochemical Assays
Biochemical tests on individual mosquitoes were con-
ducted to determine the activity of mixed function oxidas-
es and nonspecific esterases present in pyrethroid-resistant
and -susceptible samples of An. gambiae from the Ladji
and Malanville sites. Tests were conducted on 3-day-old
adult females (initially collected as larvae) in microtiter
plates (13). Susceptible (Kisumu) and pyrethroid-resistant
(Vkper) An. gambiae served as controls. Genotyping of
An. gambiae was carried out to assess kdr frequency at
both field stations (14).
Adult Bioassay Data
To determine whether a stronger pyrethroid resistance
mechanism was present in the Ladji population than in the
standard kdr strain Vkper, bioassays with 0.05% lambda-
cyalothrin-treated papers (18 mg/m2) were conducted in
WHO resistance test kits by using a range of exposure
times on batches of 25 unfed An. gambiae females 2–5
days of age. One hundred mosquitoes per exposure period
were tested. Deaths were scored 24 h later. Log-time mor-
tality curves were generated, and lethal time to kill 50%
(LT50), estimated by using probit analysis.
Data Analysis
Proportional data from the hut trial (exophily, blood-
feeding, deaths) were analyzed by using logistic regression
(STATA 6 software,  Stata Corporation, College Station,
TX, USA). Deterrence rates were analyzed by comparing
the number of mosquitoes entering each hut by using the
Wilcoxon rank sum test. Biochemical activity was ana-
lyzed with Kruskal-Wallis and Wilcoxon rank sum tests.
The level of resistance to lambdacyalothrin in insecticide
bioassays was analyzed by using probit analysis.
Results
Insecticide Residual Activity
Residual activity on ITN as measured by cone bioas-
say tests showed no decline during the 8 weeks of the trial.
Activity of the IRS wettable powder formulation on sack-
cloth and cement showed a decline in performance by
week 4. This trend continued until the end of the trial
(Table 1).
Efficacy of Treatments in Huts
Over the 2-month trial, 1,395 An. gambiae, 3,070 Cx.
quinquefasciatus, and small numbers of Mansonia uni-
formis, An. pharoensis, and Aedes aegypti were collected
at Ladji. At Malanvile, 1,523 An. gambiae, 2,804
Mansonia sp., and smaller numbers of An. funestus and Ae.
aegypti were collected. Only the malaria vector An. gam-
biae and the nuisance mosquito Cx. quinquefasciatus were
analyzed further.
Fewer An. gambiae entered the ITN- and IRS-treated
huts than the respective control huts. The treatment
induced reduction in hut entry was more evident in the
resistance area than in the susceptible area (Table 2). The
proportion deterred at each site did not differ between ITN
or IRS treatments.
The untreated net was little or no barrier to blood-
feeding of An. gambiae at either field site owing to the
large number of holes cut in each net. Treating the holed
net with pyrethroid led to a 96% reduction in the number
of mosquitoes blood-feeding at the susceptible site
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resistant site (Ladji). Inhibition of blood-feeding by IRS at
either the resistant or susceptible site was limited (Table 2).
Natural mortality of An. gambiae occurred in both
types of control huts but was notably higher at Ladji than
at Malanville. Both modes of treatment were highly insec-
ticidal at Malanville: ITNs treated with 18 mg/m2 lambda-
cyhalothrin killed 99%, and IRS applied at 30 mg/m2
killed 72% of An. gambiae that entered the huts. At Ladji,
the proportions of An. gambiae killed in either the ITN- or
IRS-treated hut did not exceed 30% (Table 2).
The proportion of An. gambiae collected from the
veranda traps in the mornings was greater at Malanville
than at Ladji and greater in the huts with untreated nets
than in the unsprayed control huts. Relative to the con-
trols, lambdacyalothrin-treated nets and IRS induced little
or no exophily of the pyrethroid-resistant An. gambiae
into the verandas of the Ladji huts, despite high survival
rate of mosquitoes in huts. At Malanville, pyrethroid-
induced exophily by ITN or IRS hut was not evident and
may have been obscured by the high death rates among
the mosquitoes.
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100% in the susceptible area. Despite the low mortality
rate and high rate of blood-feeding observed with ITN in
the resistance area, the level of personal protection there
was almost 50% because of the deterrent effect of lambda-
cyhalothin on mosquito entry into huts. The personal pro-
tective effect of IRS was low in both areas, and IRS was no
barrier to blood-feeding. The overall insecticidal effect of
pyrethroid-treated nets and IRS was negligible in the
resistance area (<5.4%) but was considerable in the sus-
ceptible area (>55.8%).
Table 3 breaks down the mortality data into 2-week
blocks. Mortality associated with IRS treatments
decreased week by week at both sites but started at a lower
rate at the Ladji site because of the expression of resist-
ance. Mortality associated with ITN treatments also
showed a downward trend over time at Ladji but not at
Malanville, where mosquitoes showed high susceptibility
throughout the study.
Both ITN and IRS treatments at Ladji showed poor
efficacy against Cx. quinquefasciatus (this species was not
encountered in Malanville). Insecticide-induced deter-
rence was greater for ITN than for IRS (Table 4). Neither
method killed many Culex nor stimulated repellency into
verandas. The IRS treatment produced an unusually high
level of blood-feeding inhibition. 
Biochemical Assays and kdr Genotyping
An. gambiae from Ladji expressed a significantly
higher level of oxidase activity than the standard suscepti-
ble (Kisumu) and the laboratory kdr (Vkper) strains, which
had a similar level of oxidase activity. However, the
pyrethroid-susceptible strain from Malanville showed a
level of oxidase activity that was not significantly different
from that of the Ladji strain. This finding would appear to
rule out any contribution from oxidases to the pyrethroid
resistance observed in An. gambiae from Ladji. The level
of α-esterase activity in An. gambiae from Ladji was sig-
nificantly higher than that expressed in Malanville or
Kisumu strains, whereas the level of β-esterase activity in
Ladji, Vkper, and Kisumu strains was similar and clearly
played no part in resistance (Table 5). Overall, the mean
level of esterase activity at Malanville was significantly
lower than that of the susceptible reference strain (p<0.05).
Genotyping data (Table 6) showed a high frequency of kdr
resistance at Ladji (F [kdr] = 83%, n = 45) and low fre-
quency at Malanville (F [kdr] = 6%, n = 45). The
pyrethroid- resistant Vkper was fixed for the Kdr gene (F
[kdr] = 100%, n = 47).
Adult Bioassays
The summary results of the exposure time mortality
bioassays with lambdacyhalothin-treated papers in WHO
cylinder kits are shown in Table 6. The slopes and LT50s of
the probit regression curves were not significantly differ-
ent for Ladji and Vkper strains. Tests on the Kisumu strain
produced 100% mortality after only 1 min exposure. An
LT50 could not be calculated by using probit analysis, but
the resistance factor in the Ladji and Vkper strains was at
least 10-fold.
Discussion
A major loss of efficacy associated with pyrethroid
resistance occurred in An. gambiae at Ladji, Benin. The
reduction in efficacy affected IRS and ITNs equally: only
19% of mosquitoes in the ITN hut and only 22% in the IRS
hut were killed after correction for natural mortality. By
contrast, 98% of mosquitoes entering the ITN hut and 72%
entering the IRS hut located in the susceptible north of
Benin were killed by the lambdacyhalothin treatments
after correction for natural mortality. These findings are
the first clear evidence of pyrethroids’failing to control an
An. gambiae population that contains kdr resistance at high
levels. Whereas the loss of insecticidal effect was calculat-
ed to be >95%, a degree of personal protection associated
with ITNs and IRS was still evident (45%–50%) relative to
the untreated net or unsprayed hut owing to a partial deter-
rent effect of treatments on entry of mosquitoes rather than
to any inhibition of blood-feeding once the insects were
inside the huts. Indeed, on entering the huts, most mosqui-
toes did go on to blood-feed, and the deliberately holed
ITN was no barrier to resistant mosquitoes. By contrast, in
northern Benin, only 4% of the insecticide-susceptible
mosquitoes that entered the hut fed through the holed ITN.
The loss of personal protection and loss of mosquito mor-
tality associated with resistance would presumably com-
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both the individual user and the malaria control manager.
Incision of 80 holes per net is the standard for ITN trials in
West Africa (8,9,12), and such nets have given a degree of
personal protection in earlier trials. An ITN with no or few
holes might be expected to give some protection against
resistant mosquitoes from Ladji, but there were insuffi-
cient huts available to test this idea.
These experimental hut results from southern Benin
stand in contrast to results from an area of Côte d’Ivoire
(Yaokoffikro) that had a comparable frequency of kdr
(78%) to that of Ladji (83%) (15) and where lambdacy-
halothrin-treated nets and other ITN showed continuing
efficacy, with mortality rates of 45%–68% (8,16–19).
We sought evidence that other resistance mechanisms
than kdr might be contributing to the reduced efficacy of
pyrethroids at Ladji. Metabolic resistance due to mixed
function oxidases (MFO) has, for example, undermined
attempts at malaria control with deltamethrin residual
spraying in southern Africa caused by An. funestus (6), and
elevated MFO activity in a strain of An. gambiae from
Cameroon reduced the efficacy of permethrin-treated net-
ting in laboratory tests (20). The combined elevated activ-
ity of MFOs, glutathione S–transferase, and esterases
resulted in a failure of the S. Mexican IRS program against
An. albimanus (21). Our examination of enzymatic activi-
ty in An. gambiae showed no evidence that MFO activity
is any greater in mosquitoes from Ladji than in mosquitoes
from Malanville, nor did esterase activity differ between
Ladji and Vkper (kdr) strains. Thus, there was no evidence
of metabolic resistance enhancing the resistance already
caused by kdr in mosquitoes from Ladji. Lambda-
cyhalothin bioassay tests showed no evidence of resistance
level differing between Ladji and Vkper strains, and we
conclude that metabolic mechanisms made no contribution
to the observations in Ladji.
In East Africa a different type of kdr based on a
leucine-to-serine mutation, which confers resistance to
permethrin and DDT (22), has been detected in several
countries. However, no mosquitoes of this genotype were
detected in tests on samples of An. gambiae from Ladji
(23). The complete absence of efficacy of lambda-
cyalothrin against Cx. quinquefasciatus in Ladji merely
confirms earlier findings involving other types of
pyrethroid in experimental huts in West Africa (6,9,16,18).
The contribution of kdr to pyrethroid resistance in An.
gambiae needs to be reappraised. While lambdacyhaloth-
in-treated nets (reported here) and permethrin-treated nets
reported earlier (24) were less effective in hut trials in the
kdr area of Benin (Ladji) than in a corresponding area of
Côte d’Ivoire (Yaokoffikro), pyrethroid-treated nets were
more effective in the susceptible area of Benin
(Malanville) than in the corresponding susceptible area of
Côte d’Ivoire (M’Be) (9) for reasons that are presently
unknown. Other differences between the biology of An.
gambiae from Côte d’Ivoire and Benin exist. Ivorian An.
gambiae with  kdr is mainly of the S molecular form,
whereas Beninoise An. gambiae is of the M form (V.
Corbel, unpub. data). M and S forms differ in ecologic dis-
tribution and habitat. While mosquitoes of the M form with
kdr might behave differently from those of the S form with
kdr when exposed to pyrethroids, this is mere speculation.
Moreover, the M form in Malanville showed higher vul-
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Côte d’Ivoire, a finding that seems at odds with a behav-
ioral hypothesis.
Our study provides persuasive evidence that
pyrethroid resistance in Benin is capable of undermining
control measures based on ITN. Nor is there reassurance to
be taken from IRS, and any attempt to switch vector con-
trol strategy would seem doomed to fail. Whereas the ear-
lier phase 3 malaria control trials of ITN in Côte d’Ivoire
showed continuing effectiveness despite kdr at high levels
(10), our phase 2 results from Benin give no grounds for
optimism. However, only phase 3 can provide a definitive
answer. Further phase 3 trials using pyrethroid-treated nets
and IRS need to be undertaken in Benin in an area of
pyrethroid resistance. The normal practice with phase 3 is
to aim at complete community coverage. Coverage in real
life is usually less than total, and the danger with the type
of pyrethroid resistance found in Benin is that at lower lev-
els of coverage the important mass protective effect of
ITNs (25,26) may be lost and transmission may continue
unabated among those who do not have ITNs. To establish
whether this is true, phase 3 trials on resistant mosquito
populations should ideally set the coverage level at
<100%. If it is considered unacceptable to deny a section
of the trial population access to ITNs, an alternative but
much less rigorous approach would be to monitor malaria
incidence among users and nonusers of long-lasting insec-
ticide nets (LLIN) during the proposed scaling up of LLIN
coverage in Benin currently being considered.
Pyrethroid resistance in Benin is far from homoge-
neous, and LLIN should give good protection wherever
mosquito populations are susceptible. Use of LLIN should
be encouraged but scale-up of treated nets may ultimately
select for further resistance. The need to develop alterna-
tive insecticides to replace or supplement pyrethroids on
nets is urgent and should be put on a par with the seeking
of new antimalarial drugs or vaccines that have received
far greater attention and resources in recent years.
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